Tomonari Awaya

1.8k total citations
55 papers, 1.1k citations indexed

About

Tomonari Awaya is a scholar working on Molecular Biology, Genetics and Cognitive Neuroscience. According to data from OpenAlex, Tomonari Awaya has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Genetics and 7 papers in Cognitive Neuroscience. Recurrent topics in Tomonari Awaya's work include Genetics and Neurodevelopmental Disorders (8 papers), Muscle Physiology and Disorders (7 papers) and Autism Spectrum Disorder Research (7 papers). Tomonari Awaya is often cited by papers focused on Genetics and Neurodevelopmental Disorders (8 papers), Muscle Physiology and Disorders (7 papers) and Autism Spectrum Disorder Research (7 papers). Tomonari Awaya collaborates with scholars based in Japan, United States and Germany. Tomonari Awaya's co-authors include Tatsutoshi Nakahata, Toshio Heike, Takeo Kato, Masatoshi Hagiwara, Hidehiro Toh, Masato Ono, Takashi Miyata, Akira Niwa, Katsutsugu Umeda and Hsi Chang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Tomonari Awaya

53 papers receiving 1.1k citations

Peers

Tomonari Awaya
María Morell Spain
Naohide Ageyama Japan
Petr Vodička Czechia
Danielle E. Dye Australia
Shin’ichiro Yasunaga Japan
Roberto H. Herai Brazil
Canquan Zhou China
Dafna Bonneh‐Barkay United States
María Morell Spain
Tomonari Awaya
Citations per year, relative to Tomonari Awaya Tomonari Awaya (= 1×) peers María Morell

Countries citing papers authored by Tomonari Awaya

Since Specialization
Citations

This map shows the geographic impact of Tomonari Awaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomonari Awaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomonari Awaya more than expected).

Fields of papers citing papers by Tomonari Awaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomonari Awaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomonari Awaya. The network helps show where Tomonari Awaya may publish in the future.

Co-authorship network of co-authors of Tomonari Awaya

This figure shows the co-authorship network connecting the top 25 collaborators of Tomonari Awaya. A scholar is included among the top collaborators of Tomonari Awaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomonari Awaya. Tomonari Awaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iida, Kei, Masahiko Ajiro, Tomonari Awaya, et al.. (2023). PDIVAS: Pathogenicity predictor for Deep-Intronic Variants causing Aberrant Splicing. BMC Genomics. 24(1). 601–601. 12 indexed citations
2.
Mikawa, Ryuta, Yukiko Okuno, Tomonari Awaya, et al.. (2023). Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC. iScience. 26(10). 107731–107731. 2 indexed citations
3.
Awaya, Tomonari, Y Sako, Megumu Ogawa, et al.. (2023). Branchpoints as potential targets of exon-skipping therapies for genetic disorders. Molecular Therapy — Nucleic Acids. 33. 404–412. 6 indexed citations
4.
Hirai, Masahiro, Takeo Kato, Takahiro Ikeda, et al.. (2022). Comparison of the Social Responsiveness Scale-2 among Individuals with Autism Spectrum Disorder and Williams Syndrome in Japan. Journal of Autism and Developmental Disorders. 54(8). 3176–3184. 3 indexed citations
5.
Ajiro, Masahiko, Tomonari Awaya, Kei Iida, et al.. (2021). Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia. Nature Communications. 12(1). 4507–4507. 25 indexed citations
6.
Awaya, Tomonari, Mami Matsuo‐Takasaki, Miho Takami, et al.. (2021). Generation of two human induced pluripotent stem cell lines derived from two X-linked adrenoleukodystrophy patients with ABCD1 mutations. Stem Cell Research. 53. 102337–102337. 4 indexed citations
7.
Kimura, Ryo, Roy Lardenoije, Kiyotaka Tomiwa, et al.. (2020). Integrated DNA methylation analysis reveals a potential role for ANKRD30B in Williams syndrome. Neuropsychopharmacology. 45(10). 1627–1636. 9 indexed citations
8.
Kimura, Ryo, Kiyotaka Tomiwa, Ryo Inoüe, et al.. (2020). Dysregulation of the oxytocin receptor gene in Williams syndrome. Psychoneuroendocrinology. 115. 104631–104631. 8 indexed citations
9.
Kimura, Ryo, et al.. (2019). MicroRNA profiling in adults with high-functioning autism spectrum disorder. Molecular Brain. 12(1). 82–82. 32 indexed citations
10.
Kimura, Ryo, Yasuko Funabiki, Shiho Suzuki, et al.. (2019). An epigenetic biomarker for adult high-functioning autism spectrum disorder. Scientific Reports. 9(1). 26 indexed citations
11.
Samata, Bumpei, Tomonari Awaya, Jun Takahashi, et al.. (2019). Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model. Journal of Human Genetics. 64(5). 445–458. 4 indexed citations
12.
Kimura, Ryo, Vivek Swarup, Kiyotaka Tomiwa, et al.. (2018). Integrative network analysis reveals biological pathways associated with Williams syndrome. Journal of Child Psychology and Psychiatry. 60(5). 585–598. 21 indexed citations
13.
Yoshida, Takeshi, Tomonari Awaya, Ryo Kimura, et al.. (2017). A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells. Scientific Reports. 7(1). 42 indexed citations
14.
Nakano-Kobayashi, Akiko, Tomonari Awaya, Isao Kii, et al.. (2017). Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice. Proceedings of the National Academy of Sciences. 114(38). 10268–10273. 61 indexed citations
15.
Shoji, Emi, Hidetoshi Sakurai, Tatsutoshi Nakahata, et al.. (2015). Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells. Scientific Reports. 5(1). 12831–12831. 90 indexed citations
16.
Yoshida, Takeshi, Tomonari Awaya, Minoru Shibata, et al.. (2014). Hypergonadotropic hypogonadism and hypersegmented neutrophils in a patient with ataxia‐telangiectasia‐like disorder: Potential diagnostic clues?. American Journal of Medical Genetics Part A. 164(7). 1830–1834. 9 indexed citations
17.
Nakahata, Tatsutoshi, Tomonari Awaya, Akira Niwa, et al.. (2010). Derivation of Engraftable Myogenic Precursors from Murine ES/iPS cells and Generation of Disease-specific iPS cells from Patients with Duchenne Muscular dystrophy (DMD) and Other Diseases. Rinsho Shinkeigaku. 50(11). 889–889. 3 indexed citations
18.
Kato, Itaru, Katsutsugu Umeda, Tomonari Awaya, et al.. (2009). Successful treatment of refractory donor lymphocyte infusion‐induced immune‐mediated pancytopenia with rituximab. Pediatric Blood & Cancer. 54(2). 329–331. 1 indexed citations
19.
Yamaguchi, Etsuro, Hiroatsu Agata, Toru Komatsu, et al.. (2008). A combination therapy of whole lung lavage and GM‐CSF inhalation in pulmonary alveolar proteinosis. Pediatric Pulmonology. 43(8). 828–830. 31 indexed citations
20.
Ohtaki, Kohei, Keiko Matsubara, Keiko Shimizu, et al.. (2004). Cefoselis, a ?-lactam antibiotic, easily penetrates the blood-brain barrier and causes seizure independently by glutamate release. Journal of Neural Transmission. 111(12). 1523–1535. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Morell Breakdown of academic impact, for papers by Naohide Ageyama Breakdown of academic impact, for papers by Petr Vodička Breakdown of academic impact, for papers by Danielle E. Dye Breakdown of academic impact, for papers by Shin’ichiro Yasunaga Breakdown of academic impact, for papers by Roberto H. Herai Breakdown of academic impact, for papers by Canquan Zhou Breakdown of academic impact, for papers by Dafna Bonneh‐Barkay
Rankless by CCL
2026